Name of study:
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Targeted disease:
Lung Cancer
Purpose of study:
International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinical impact on pts with advanced cancer to facilitate clinical trial enrollment (CTE), as well as the financial impact, and potential outcomes of the intervention.
Is the study of a controlled or observational design?
Observational
Where is the study being conducted?
Multi-Center Trial
Lead Institution:
Massive Bio, Inc
City and State:
Nationwide
When the study is being conducted:
Start Date: 1/1/2018
End date: 12/1/2022
What website should a person use to register for the study?
Massivebio.com
Who should a person contact to register for the study?
Name: Massive Bio
Phone: 844-627-7246
Email: [email protected]
Who is sponsoring this study?
Massive Bio, Inc.
What is the identifier for this study on ClinicalTrials.gov?
NCT03452774
Page last updated: February 23, 2021